Snapshot from Jun 26, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Cadonilimab
Other

Cadonilimab

Tracked across 1 events · 33 articles · First seen May 25, 2026 · Last active Jun 08, 2026

Sentiment
65
Attention
7
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
7 65
Tech
ASCO 2026 Oncology Research Presentations
The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago from May 29 to June 2, served as a crucial platform for major pharmaceutical and biotechnology companies to present significant advancements in…
Impact: Cadonilimab is another core first-in-class bispecific antibody from Akeso's portfolio, with regimens being presented for various tumor types at ASCO 2026, indicating its potential clinical benefits.
May 25, 2026 · 33 articles
Key Actions (1)
85 Akeso presented clinical data CadonilimabASCO 2026 Oncology...
NEWSDESK
Track Cadonilimab live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.